NASDAQ · STOCK
ResMed
$211.00
52W $180.27 – $293.81
57/100
$30.60B
20.3
0.78
Is RMD Bullish or Bearish?
Mixed.
Innellis AI committee rates ResMed (RMD) Watch with a composite score of 57/100
, based on 7 analysts with 71% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +2.66 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -17.34 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Some positive signals exist — news sentiment is positive (+0.39 across 6 articles, 14d) — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.
Bull & Bear Case
Bull Case
- ROE of 24.4% shows genuine earnings power backing the valuation — Value
- MACD histogram positive -- bullish momentum — Technical
- Low leverage (debt-to-equity 0.11) -- balance sheet can absorb a shock — Risk
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.39 across 6 articles, 14d) — News
Bear Case
- Price-to-book of 6.3x prices in significant intangible value — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- Bollinger bandwidth of 16.2% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
57/100
Agreement
71%
Analysts
7
Conviction
Moderate
Sector Rank
Top 31%
of 93 Healthcare peers
Value Analyst
neutral
59
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 24.4% shows genuine earnings power backing the valuation
− Price-to-book of 6.3x prices in significant intangible value
Growth Analyst
neutral
50
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
bullish
62
/ 100 · Moderate confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.11) -- balance sheet can absorb a shock
− Bollinger bandwidth of 16.2% signals elevated volatility
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
70
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.39 across 6 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 57.4 to 57.3.
- Conviction changed from contested to moderate.
- Committee agreement increased notably from 57% to 71%.
- New bearish signals: 3 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 2 appeared.
- Bearish pressure eased: 4 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Risk Analyst: +1 bearish signal(s).
- Technical Analyst: score 48->58 (+10).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
62.7
Neutral
MACD Histogram
1.435
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$180.58
Resistance
$259.98
Bollinger %B
0.73
Inside Bands
Price vs Moving Averages
EMA 9
$205.50
Above
EMA 21
$202.71
Above
EMA 50
$203.43
Above
EMA 200
$225.81
Below
Fundamental Analysis
Valuation
72
Growth
63
Profitability
1
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio
20.3×
P/B Ratio
4.76×
PEG Ratio
1.27
Dividend Yield
0.01%
52W High
$293.81
52W Low
$180.27
Quality & Growth
ROE
23.5%
ROA
17.1%
Gross Margin
61.7%
Operating Margin
34.3%
Revenue Growth YoY
—
Debt / Equity
0.13
AI Fundamental Assessment
P/E ratio of 20.3 (inexpensive relative to a 15-40x range); Price-to-book of 4.8x; PEG ratio of 1.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.2%; Net margin of 0.3%; Gross margin of 0.6%; Current ratio of 3.01 (healthy short-term liquidity); Debt-to-equity of 0.13; Free cash flow margin of 0.9% (thin cash generation); Free cash flow per share is positive (11.94); Most recent quarter beat estimates by 1.3%; 2 consecutive earnings beats; EPS growth decelerating (+10.2% -> +1.8% QoQ); Analyst estimates rising over recent quarters
Get the Full RMD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →